Rapid Identification of Antifungal Compounds against Exserohilum rostratum Using High Throughput Drug Repurposing Screens

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Sun, Wei ^a   Park, Yoon Dong ^b   Sugui, Janyce A ^b   Fothergill, Annette ^c   Southall, Noel ^a   Shinn, Paul ^a   McKew, John C ^a   Kwon Chung, Kyung J ^b   Zheng, Wei ^a   Williamson, Peter R ^b,d  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^d UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOROLFINE; AMPHOTERICIN B; ANTIFUNGAL AGENT; AZOXYSTROBIN; BROXYQUINOLINE; CAPTAN; CLIOQUINOL; DEQUALINIUM; DEQUALINIUM DICHLORIDE; ENILCONAZOLE; FENTICLOR; FLOXURIDINE; FLUCONAZOLE; HEXACHLOROPHENE; ITRACONAZOLE; KETOCONAZOLE; LANOCONAZOLE; LULICONAZOLE; PENTAMIDINE ISETHIONATE; PHENYLMERCURIC ACETATE; POSACONAZOLE; PYRROLNITRIN; TACROLIMUS; TERCONAZOLE; THERMOZYMOCIDIN; THIOMERSAL; TIOCONAZOLE; TRITICONAZOLE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VORICONAZOLE;

ARTICLE; CENTRAL NERVOUS SYSTEM INFECTION; CONIDIUM; CONTROLLED STUDY; DRUG APPROVAL; DRUG DETERMINATION; DRUG EFFICACY; DRUG IDENTIFICATION; DRUG MECHANISM; DRUG REPOSITIONING; DRUG STRUCTURE; EXSEROHILUM ROSTRATUM; FUNGICIDAL ACTIVITY; FUNGUS; FUNGUS HYPHAE; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; IC 50; MYCOSIS; NONHUMAN;

ADENOSINE TRIPHOSPHATE; AMPHOTERICIN B; ANTIFUNGAL AGENTS; ASCOMYCOTA; BITHIONOL; CELL LINE, TUMOR; DRUG EVALUATION, PRECLINICAL; DRUG REPOSITIONING; FLOXURIDINE; HUMANS; HYPHAE; SEPSIS; SPORES, FUNGAL; TACROLIMUS; TRIAZOLES;

EID: 84882667253     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0070506     Document Type: Article

References (52)

1. Kainer MA, Reagan DR, Nguyen DB, Wiese AD, Wise ME, et al. (2012) Fungal infections associated with contaminated methylprednisolone in Tennessee. The New England journal of medicine 367: 2194-2203.
2. Kauffman CA, Pappas PG, Patterson TF, (2012) Fungal Infections Associated with Contaminated Methylprednisolone Injections- Preliminary Report. The New England journal of medicine.
3. Smith RM, Schaefer MK, Kainer MA, Wise M, Finks J, et al. (2012) Fungal Infections Associated with Contaminated Methylprednisolone Injections- Preliminary Report. The New England journal of medicine.
4. Kerkering TM, Grifasi ML, Baffoe-Bonnie AW, Bansal E, Garner DC, et al. (2013) Early Clinical Observations in Prospectively Followed Patients With Fungal Meningitis Related to Contaminated Epidural Steroid Injections. Annals of internal medicine 158: 154.
5. Finks J, Collins J, Miller C, et al. (2013) Spinal and paraspinal infections associated with contaminated methylprednisolone acetate injections- michigan, 2012-2013. MMWR Morbidity and mortality weekly report 62: 377-381.
6. Adler A, Yaniv I, Samra Z, Yacobovich J, Fisher S, et al. (2006) Exserohilum: an emerging human pathogen. European journal of clinical microbiology & infectious diseases: official publication of the European Society of Clinical Microbiology 25: 247-253.
7. Lin SC, Sun PL, Ju YM, Chan YJ, (2009) Cutaneous phaeohyphomycosis caused by Exserohilum rostratum in a patient with cutaneous T-cell lymphoma. International journal of dermatology 48: 295-298.
8. Juhas E, Reyes-Mugica M, Michaels MG, Grunwaldt LJ, Gehris RP, (2012) Exserohilum Infection in an Immunocompromised Neonate. Pediatric dermatology.
9. Huang R, Southall N, Wang Y, Yasgar A, Shinn P, et al. (2011) The NCGC pharmaceutical collection: a comprehensive resource of clinically approved drugs enabling repurposing and chemical genomics. Science translational medicine 3: 80ps16.
10. Chen CZ, Kulakova L, Southall N, Marugan JJ, Galkin A, et al. (2011) High-throughput Giardia lamblia viability assay using bioluminescent ATP content measurements. Antimicrobial agents and chemotherapy 55: 667-675.
11. Miller SC, Huang R, Sakamuru S, Shukla SJ, Attene-Ramos MS, et al. (2010) Identification of known drugs that act as inhibitors of NF-kappaB signaling and their mechanism of action. Biochemical pharmacology 79: 1272-1280.
12. Shen M, Zhang Y, Saba N, Austin CP, Wiestner A, et al. (2013) Identification of Therapeutic Candidates for Chronic Lymphocytic Leukemia from a Library of Approved Drugs. Manuscript in submission.
13. Xia M, Huang R, Sakamuru S, Alcorta D, Cho M, et al. (2013) Identification of repurposed small molecule drugs for chordoma therapy. Cancer Biology and Therapy In press.
14. Xu M, Liu K, Swaroop M, Porter FD, Sidhu R, et al. (2012) delta-Tocopherol reduces lipid accumulation in Niemann-Pick type C1 and Wolman cholesterol storage disorders. The Journal of biological chemistry 287: 39349-39360.
15. Yuan H, Myers S, Wang J, Zhou D, Woo JA, et al. (2012) Use of reprogrammed cells to identify therapy for respiratory papillomatosis. The New England journal of medicine 367: 1220-1227.
16. Richard JL, Cysewski SJ, Fichtner RE, (1971) Harvest and survival of aspergillus fumigatus Fresenius spores. Mycopathologia et mycologia applicata 43: 165-168.
17. Masuko T, Minami A, Iwasaki N, Majima T, Nishimura S, et al. (2005) Carbohydrate analysis by a phenol-sulfuric acid method in microplate format. Analytical biochemistry 339: 69-72.
18. Lea WA, Xi J, Jadhav A, Lu L, Austin CP, et al. (2009) A high-throughput approach for identification of novel general anesthetics. PloS one 4: e7150.
19. Wang Y, Jadhav A, Southal N, Huang R, Nguyen DT, (2010) A grid algorithm for high throughput fitting of dose-response curve data. Current chemical genomics 4: 57-66.
20. CLSI (2012) Reference method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Fourth Informational Supplement. CLSI document M27-S4 Wayne: Clinical and Laboratory Standards Institute (CLSI).
21. Diamond RD, Bennett JE, (1974) Prognostic Factors in Cryptococcal Meningitis- Study in 111 Cases. Annals of internal medicine 80: 176-181.
22. Lewis JS, Graybill JR, (2008) Fungicidal versus fungistatic: what"s in a word? Expert opinion on pharmacotherapy 9: 927-935.
23. National Committee for Clinical Laboratory Standards (2008) Reference Method for Broth Dilution Susceptibility Testing of Filamentous Fungi: Approved Standard-Second Edition. Wayne, PA: Clinical and Laboratory Standards Institute.
24. Nakagawa H, Yamada M, Fukushima M, Shimizu K, Ikenaka K, (1998) In vivo study on intrathecal use of 5-fluoro-2 ′-deoxysuridine (FdUrd) in meningeal dissemination of malignant tumor. Neurological Surgery 26: 873-879.
25. Wang JX, Sun X, Zhang ZR, (2002) Enhanced brain targeting by synthesis of 3 ′,5 ′-dioctanoyl-5-fluoro-2 ′-deoxyuridine and incorporation into solid lipid nanoparticles. European Journal of Pharmaceutics and Biopharmaceutics 54: 285-290.
26. Berthet N, Faure O, Bakri A, Ambroise-Thomas P, Grillot R, et al. (2003) In vitro susceptibility of Aspergillus spp. clinical isolates to albendazole. J Antimicrob Chemother 51: 1419-1422.
27. Rabjohns JLA, Park YD, Dehdashti J, Zheng W, Williamson PR, (2013) A High Throughput Screening Assay for Fungicidal Compounds against Cryptococcus neoformans. Journal of Bimolecular Screen In submission.
28. Cho SH, Warit S, Wan B, Hwang CH, Pauli GF, et al. (2007) Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis. Antimicrobial agents and chemotherapy 51: 1380-1385.
29. Coconnier-Polter MH, Lievin-Le Moal V, Servin AL, (2005) A Lactobacillus acidophilus strain of human gastrointestinal microbiota origin elicits killing of enterovirulent Salmonella enterica Serovar Typhimurium by triggering lethal bacterial membrane damage. Applied and environmental microbiology 71: 6115-6120.
30. Hu G, Hacham M, Waterman SR, Panepinto J, Shin S, et al. (2008) PI3K signaling of autophagy is required for starvation tolerance and virulenceof Cryptococcus neoformans. The Journal of clinical investigation 118: 1186-1197.
31. Kim K, Pollard JM, Norris AJ, McDonald JT, Sun Y, et al. (2009) High-throughput screening identifies two classes of antibiotics as radioprotectors: tetracyclines and fluoroquinolones. Clinical cancer research: an official journal of the American Association for Cancer Research 15: 7238-7245.
32. Kusari S, Zuhlke S, Kosuth J, Cellarova E, Spiteller M, (2009) Light-independent metabolomics of endophytic Thielavia subthermophila provides insight into microbial hypericin biosynthesis. Journal of natural products 72: 1825-1835.
33. Kangas L, Gronroos M, Nieminen AL, (1984) Bioluminescence of cellular ATP: a new method for evaluating cytotoxic agents in vitro. Medical biology 62: 338-343.
34. Cree IA, Andreotti PE, (1997) Measurement of cytotoxicity by ATP-based luminescence assay in primary cell cultures and cell lines. Toxicology in vitro: an international journal published in association with BIBRA 11: 553-556.
35. Esser L, Quinn B, Li YF, Zhang MQ, Elberry M, et al. (2004) Crystallographic studies of quinol oxidation site inhibitors: A modified classification of inhibitors for the cytochrome bc(1) complex. Journal of Molecular Biology 341: 281-302.
36. Rousk J, Demoling LA, Baath E, (2009) Contrasting Short-Term Antibiotic Effects on Respiration and Bacterial Growth Compromises the Validity of the Selective Respiratory Inhibition Technique to Distinguish Fungi and Bacteria. Microbial Ecology 58: 75-85.
37. Tripathi RK, Gottlieb D, (1969) Mechanism of action of the antifungal antibiotic pyrrolnitrin. Journal of bacteriology 100: 310-318.
38. Frederick JJ, Corner TR, Gerhardt P, (1974) Antimicrobial actions of hexachlorophene: inhibition of respiration in Bacillus megaterium. Antimicrobial agents and chemotherapy 6: 712-721.
39. Miyake Y, Kozutsumi Y, Nakamura S, Fujita T, Kawasaki T, (1995) Serine Palmitoyltransferase Is the Primary Target of a Sphingosine-Like Immunosuppressant, Isp-1/Myriocin. Biochemical and Biophysical Research Communications 211: 396-403.
40. Yamaji-Hasegawa A, Takahashi A, Tetsuka Y, Senoh Y, Kobayashi T, (2005) Fungal metabolite sulfamisterin suppresses sphingolipid synthesis through inhibition of serine palmitoyltransferase. Biochemistry 44: 268-277.
41. Melnick JG, Yurkerwich K, Buccella D, Sattler W, Parkin G, (2008) Molecular structures of thimerosal (Merthiolate) and other arylthiolate mercury alkyl compounds. Inorganic Chemistry 47: 6421-6426.
42. Geier J, Lessmann H, Uter W, Schnuch A, (2005) Patch testing with phenylmercuric acetate. Contact Dermatitis 53: 117-118.
43. Hecht SM, (2000) Bleomycin: New perspectives on the mechanism of action. Journal of natural products 63: 158-168.
44. Murakami Y, Kazuno H, Emura T, Tsujimoto H, Suzuki N, et al. (2000) Different mechanisms of acquired resistance to fluorinated pyrimidines in human colorectal cancer cells. International Journal of Oncology 17: 277-283.
45. Graham J, Muhsin M, Kirkpatrick P, (2004) Oxaliplatin. Nature Reviews Drug Discovery 3: 11-12.
46. Cortat M, (1978) Studies on the mode of action of phenylmercuric borate on Escherichia coli. II. Biochemical localization and inhibition of some metabolic activities. Zentralblatt fur Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene Erste Abteilung Originale Reihe B: Hygiene, praventive Medizin 166: 528-539.
47. Cortat M, (1978) Studies on the mode of action of phenylmercuric borate on Escherichia coli. I. Structural localization and kinetics of incorporation. Zentralblatt fur Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene Erste Abteilung Originale Reihe B: Hygiene, praventive Medizin 166: 517-527.
48. Liu J, Farmer JD, Lane WS, Friedman J, Weissman I, et al. (1991) Calcineurin Is a Common Target of Cyclophilin-Cyclosporine-a and Fkbp-Fk506 Complexes. Cell 66: 807-815.
49. Ganne F, Vasse M, Beaudeux JL, Peynet J, Francois A, et al. (2000) Cerivastatin, an inhibitor of HMG-CoA reductase, inhibits urokinase/urokinase-receptor expression and MMP-9 secretion by peripheral blood monocytes- A possible protective mechanism against atherothrombosis. Thrombosis and Haemostasis 84: 680-688.
50. Ohmichi M, Pang L, Ribon V, Gazit A, Levitzki A, et al. (1993) The Tyrosine Kinase Inhibitor Tyrphostin Blocks the Cellular Actions of Nerve Growth-Factor. Biochemistry 32: 4650-4658.
51. Denys A, Aires V, Hichami A, Khan NA, (2004) Thapsigargin-stimulated MAP kinase phosphorylation via CRAC channels and PLD activation: inhibitory action of docosahexaenoic acid. Febs Letters 564: 177-182.
52. Abbott BJ, Fukuda DS, Dorman DE, Occolowitz JL, Debono M, et al. (1979) Microbial Transformation of A23187, a Divalent-Cation Ionophore Antibiotic. Antimicrobial agents and chemotherapy 16: 808-812.